{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T20:53:01Z","timestamp":1788900781055,"version":"build-2803163510"},"reference-count":31,"publisher":"Consilium Medicum","issue":"4","license":[{"start":{"date-parts":[[2020,4,19]],"date-time":"2020-04-19T00:00:00Z","timestamp":1587254400000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Terapevticheskii arkhiv"],"abstract":"<jats:p>Rebamipide is a mucoprotective drug which was developed in Japan in 1990. The therapeutic effect of rebamipide based on the induction of cyclooxygenase-2 and increasing level of prostaglandins, inhibition of oxygen free radicals production, epidermal growth factor stimulation, vascular endothelial growth factor, nitric oxide, and decreasing of lipid peroxidation and neutrophils migration. The combination of proton pump inhibitors and rebamipide is more effective in relieving of gastroesophageal reflux disease symptoms and reducing recurrence rate of disease. Using rebamipide in the treatment of gastroesophageal reflux disease is justified because this drug has a unique mechanism of action, which eliminating the main stages of pathogenesis of the disease.<\/jats:p>","DOI":"10.26442\/00403660.2020.04.000568","type":"journal-article","created":{"date-parts":[[2020,6,29]],"date-time":"2020-06-29T14:35:20Z","timestamp":1593441320000},"page":"98-104","source":"Crossref","is-referenced-by-count":24,"title":["Rebamipide using in gastroesophageal reflux disease treatment"],"prefix":"10.26442","volume":"92","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6815-6015","authenticated-orcid":false,"given":"V. T.","family":"Ivashkin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3362-2968","authenticated-orcid":false,"given":"A. S.","family":"Trukhmanov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0605-8057","authenticated-orcid":false,"given":"M. I.","family":"Gonik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"18344","published-online":{"date-parts":[[2020,4,19]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.22416\/1382-4376-2017-27-4-75-95"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1097\/MCG.0000000000000854"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1111\/nmo.12201"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.2492\/inflammregen.26.428"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1089\/jop.2011.0142"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-005-2800-9"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1097\/MAJ.0000000000000443"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.3164\/jcbn.40.13"},{"key":"ref9","unstructured":"\u0415\u0432\u0441\u044e\u0442\u0438\u043d\u0430 \u042e.\u0412. \u0438 \u0434\u0440. \u0421\u0438\u0441\u0442\u0435\u043c\u043d\u044b\u0439 \u0438\u043c\u043c\u0443\u043d\u043d\u044b\u0439 \u043e\u0442\u0432\u0435\u0442 \u0443 \u043f\u0430\u0446\u0438\u0435\u043d\u0442\u043e\u0432 \u0441 \u0433\u0430\u0441\u0442\u0440\u043e\u044d\u0437\u043e\u0444\u0430\u0433\u0435\u0430\u043b\u044c\u043d\u043e\u0439 \u0440\u0435\u0444\u043b\u044e\u043a\u0441\u043d\u043e\u0439 \u0431\u043e\u043b\u0435\u0437\u043d\u044c\u044e. \u0420\u043e\u0441. \u0436\u0443\u0440\u043d. \u0433\u0430\u0441\u0442\u0440\u043e\u044d\u043d\u0442\u0435\u0440\u043e\u043b\u043e\u0433\u0438\u0438, \u0433\u0435\u043f\u0430\u0442\u043e\u043b\u043e\u0433\u0438\u0438, \u043a\u043e\u043b\u043e\u043f\u0440\u043e\u043a\u0442\u043e\u043b\u043e\u0433\u0438\u0438. 2015;25(5):32-8 [Yevsyutina YuV, Trukhmanov AS. The role of esophageal and stomach motility disorders in pathogenesis of gastroesophageal reflux disease. Russian Journal of Gastroenterology, Hepatology, Coloproctology. 2015;25(5):32-8 (In Russ.)]."},{"key":"ref10","doi-asserted-by":"crossref","unstructured":"Goyal RK. Deleterious effects of prostaglandins on esophageal mucosa. Gastroenterology. 1980;5(78):1085-7.","DOI":"10.1016\/0016-5085(80)90796-9"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/532594"},{"key":"ref12","doi-asserted-by":"crossref","unstructured":"Goyal RK, Rattan S, Hersh T. Comparison of the Effects of Prostaglandins E1, E2, and A2, and of Hypovolumic Hypotension on the Lower Esophageal Sphincter. Gastroenterology. 1973;4(65):608-12.","DOI":"10.1016\/S0016-5085(19)33040-9"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.v11.i18.26"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1016\/S0891-5849(01)00472-5"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1080\/10715762.2016.1181262"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"Cheng L, Cao W, Behar J, et al. Inflammation induced changes in arachidonic acid metabolism in cat LES circular muscle. Am J Physiol Gastrointestinal Liver Physiol. 2005;4(288):G787-G797.","DOI":"10.1152\/ajpgi.00327.2004"},{"key":"ref17","unstructured":"PubChem Rebamipide. https:\/\/pubchem.ncbi.nlm.nih.gov\/compound\/5042"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/BF01308601"},{"key":"ref19","unstructured":"Sun W-H, Tsuji S, Tsujii M, et al. Induction of cyclooxygenase-2 in rat gastric mucosa by rebamipide, a mucoprotective agent. J Pharmacol Experim Ther. 2000;2(295):447-52."},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-005-2813-4"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.5009\/gnl17078"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-015-3662-4"},{"key":"ref23","doi-asserted-by":"crossref","unstructured":"Kauppila JH, Selander KS. Toll-like receptors in esophageal cancer. Frontiers Immunol. 2014;5:200.","DOI":"10.3389\/fimmu.2014.00200"},{"key":"ref24","doi-asserted-by":"crossref","unstructured":"Hong SJ, Park SH, Moon JS, et al. The Benefits of Combination Therapy with Esomeprazole and Rebamipide in Symptom Improvement in Reflux Esophagitis: An International Multicenter Study. Gut Liver. 2016;6(10):910-6.","DOI":"10.5009\/gnl15537"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-010-1166-9"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8091498"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.17116\/terarkh201789284-90"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.26442\/terarkh201890827-32"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1111\/hel.12525"},{"key":"ref30","doi-asserted-by":"crossref","unstructured":"Terano A, Arakawa T, Sugiyama T, et al; Rebamipide Clinical Study Group. Rebamipide, a gastro-protective and anti-inflammatory drug, promotes gastric ulcer healing following eradication therapy for Helicobacter pylori in a Japanese population: a randomized, double-blind, placebo-controlled trial. J Gastroenterol. 2007;42(8):690-3.","DOI":"10.1007\/s00535-007-2076-2"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-013-2606-0"}],"container-title":["Terapevticheskii arkhiv"],"original-title":[],"link":[{"URL":"https:\/\/ter-arkhiv.ru\/0040-3660\/article\/viewFile\/34115\/22448","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/ter-arkhiv.ru\/0040-3660\/article\/viewFile\/34115\/22448","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,13]],"date-time":"2021-10-13T20:48:29Z","timestamp":1634158109000},"score":1,"resource":{"primary":{"URL":"https:\/\/ter-arkhiv.ru\/0040-3660\/article\/view\/34115"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4,19]]},"references-count":31,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2020,4,19]]}},"URL":"https:\/\/doi.org\/10.26442\/00403660.2020.04.000568","relation":{},"ISSN":["2309-5342","0040-3660"],"issn-type":[{"value":"2309-5342","type":"electronic"},{"value":"0040-3660","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4,19]]}}}